Exponent, Inc. (NASDAQ:EXPO) insider John Pye sold 3,600 shares of Exponent stock in a transaction dated Monday, July 24th. The shares were sold at an average price of $65.08, for a total transaction of $234,288.00. Following the sale, the insider now owns 14,767 shares of the company’s stock, valued at $961,036.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Shares of Exponent, Inc. (EXPO) traded up 0.69% on Tuesday, hitting $65.90. 35,001 shares of the company were exchanged. The company has a 50-day moving average price of $59.54 and a 200 day moving average price of $59.14. Exponent, Inc. has a 52-week low of $48.42 and a 52-week high of $68.30. The firm has a market cap of $1.74 billion, a P/E ratio of 34.16 and a beta of 0.60.
Exponent (NASDAQ:EXPO) last posted its earnings results on Tuesday, July 18th. The business services provider reported $0.51 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.10. The firm had revenue of $84.10 million during the quarter, compared to the consensus estimate of $79.30 million. Exponent had a net margin of 15.94% and a return on equity of 16.52%. The company’s revenue was up 14.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.38 EPS. Analysts predict that Exponent, Inc. will post $1.97 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 22nd. Investors of record on Friday, September 1st will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date is Wednesday, August 30th. Exponent’s dividend payout ratio (DPR) is presently 43.52%.
A number of brokerages recently weighed in on EXPO. Cantor Fitzgerald restated an “overweight” rating and issued a $69.00 price objective (up previously from $64.00) on shares of Exponent in a report on Saturday, April 22nd. Zacks Investment Research upgraded shares of Exponent from a “hold” rating to a “buy” rating and set a $74.00 price objective for the company in a report on Thursday, July 20th. ValuEngine upgraded shares of Exponent from a “sell” rating to a “hold” rating in a report on Thursday, July 20th. Finally, BidaskClub cut shares of Exponent from a “sell” rating to a “strong sell” rating in a report on Tuesday, June 27th.
A number of hedge funds have recently bought and sold shares of the company. BlackRock Inc. increased its stake in Exponent by 41,234.4% in the first quarter. BlackRock Inc. now owns 3,080,242 shares of the business services provider’s stock worth $183,428,000 after buying an additional 3,072,790 shares during the period. Norges Bank acquired a new stake in Exponent during the fourth quarter worth about $14,612,000. Schroder Investment Management Group acquired a new stake in Exponent during the first quarter worth about $6,312,000. Conestoga Capital Advisors LLC increased its stake in Exponent by 15.6% in the second quarter. Conestoga Capital Advisors LLC now owns 727,177 shares of the business services provider’s stock worth $42,394,000 after buying an additional 98,280 shares during the period. Finally, Vanguard Group Inc. increased its stake in Exponent by 3.9% in the first quarter. Vanguard Group Inc. now owns 2,176,141 shares of the business services provider’s stock worth $129,590,000 after buying an additional 81,811 shares during the period. 90.10% of the stock is owned by hedge funds and other institutional investors.
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.